Feasibility of Using NeoSpot at Community Settings
NCT: NCT05652777 · COMPLETED
Brief Summary
Continuous vital sign monitoring is a basic tenet of specialized care in the developed world that is vastly underutilized during hospital or clinic admissions or outpatient routine visits in most low-and-middle income countries (LMICs). Despite the positive outcomes associated with vital sign monitoring (i.e., increased survival-to-discharge rates, lower complication rates and shorter length of stay in hospital), the prohibitive costs of conventional patient monitors and the difficulty in maintaining complex medical equipment limit its practice in the developing world. Currently, due to lack of medical supplies, most ANC clinics - within the health facilities or during outreach activities - do not monitor for vital signs and blood pressure among pregnant women. While many devices exist, their ease of use and high-cost, including maintenance costs, hinder screening and monitoring programs in low resource settings. Accurate and low-cost vital sign monitoring devices are required to improve identification and treatment of women with danger signs during their routine ANC visits. To meet the growing demand for vital sign monitors during the COVID-19 pandemic, Neopenda has adapted an affordable, wearable, wireless vital sign monitoring solution (neoSpotTM), that measures temperature, respiration rate, blood oxygen saturation, pulse rate, and blood pressure.
Frequently Asked Questions
What is Feasibility of Using NeoSpot at Community Settings?
Feasibility of Using NeoSpot at Community Settings is a clinical trial registered under NCT05652777. Current status: COMPLETED.
What is the status of NCT05652777?
The current status of NCT05652777 (Feasibility of Using NeoSpot at Community Settings) is: COMPLETED.
When did Feasibility of Using NeoSpot at Community Settings start?
Feasibility of Using NeoSpot at Community Settings started on 2023-01-15.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.